Cytori Therapeutics, Inc. Announces Exercise in Full of Overallotment Option and Closing of Public Offering of Common Stock; Raises $19.3 Million in Net Proceeds

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ: CYTX) closed its public offering of 4,000,000 shares of its common stock, plus 600,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriter, for a total offering of 4,600,000 shares of common stock. All of the shares were offered by Cytori. Net proceeds from the sale of the shares, after underwriting discounts and commissions and other offering expenses, are approximately $19.3 million.